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http://dx.doi.org/10.1016/j.jmu.2012Three-dimensional (3D) ultrasound is an easy, important and noninvasive method for the
differential diagnosis of ovarian disease in the clinical practice of obstetrics and gynecology.
With advances in ultrasonographic technology, the application of higher-frequency scanning
probes can evaluate the ovary in the analysis of morphological anatomy and in volume
measurement, and is highly reproducible. The potential of power Doppler ultrasound with
vascular indices that can further depict and quantify the microcirculation of the ovary has
been extensively explored. The aim of this review is to report the present status and the
recent development of 3D ultrasonography in the evaluation of the ovary. In conclusion, 3D
ultrasound examination may help us to investigate the functional and potential roles of ultra-
sonography in clinical practice concerned with the ovary. Furthermore, 3D ultrasound may
provide more substantial assistance in the differential diagnosis of various physiological or
pathological conditions of the ovary.
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.07.001Introduction
Three-dimensional (3D) ultrasound is an easy and noninva-
sive method for the differential diagnosis of various physi-
ological and pathological conditions of the ovary in the
clinical practice of obstetrics and gynecology. With
advances in 3D ultrasonographic technology, although 3D
imaging is still at a relatively early stage, the application ofof Ultrasound in Medicine. Open access under CC BY-NC-ND license.
3D Ultrasound in Evaluation of the Ovaries 137higher-frequency scanning probes can evaluate the ovary in
the analysis of morphological anatomy and in volume
measurement, and is highly reproducible [1,2]. The three
dimensions improve spatial orientation and access multi-
planar views, especially the coronal (reconstructed) plane,
which can provide additional information that can depict
lesions not easily diagnosed by two-dimensional (2D)
ultrasound imaging. It can rotate and magnify the acquired
stored volume for re-evaluation with reduced scanning time
and without increasing patient discomfort. The 3D volume
measurement of the ovary, follicles and stroma can be
determined more precisely by outlining meticulously the
region of interest. The potential of power Doppler ultra-
sound with vascular indices that can further depict and
quantify the microcirculation of the ovary is extensively
explored. Furthermore, some 3D software programs using
the virtual organ computer-aided analysis (VOCAL) system
have been developed but further work is needed to ensure
a clinically relevant benefit. The aim of this review is to
report the present status and the recent development of 3D
ultrasonography in the evaluation of the ovary.Parameters for evaluation of the ovary using
3D ultrasound
The length (one dimension) of the ovarian diameter, area
(two dimensions) and volume (three dimensions) can be
easily calculated; especially the rotatable perpendicular
planes of the ovary using 3D ultrasound. The ovarian
volumes are estimated using the trapezoid formula by 3D
ultrasound that is compared with the ellipsoid formula
(height  width  length  0.523) by conventional 2D
ultrasound scanning [3]. The most common indices of color
Doppler examination followed B mode are pulsatility index
(PI), resistance index (RI) and systole to diastole (S/D) ratio
[4]. The calculation of RI and PI is based on the following
formulas: RIZ (S  D)/S and PIZ (S  D)/mean, where S is
the peak systolic velocity, D is the end diastolic velocity and
the mean is the averaged maximum velocity.
SonoAVC (Automatic Volume Calculation) is a software
program that can identify and quantify ovarian hypoecho-
genic regions within a 3D dataset and provide automatic
estimation of their absolute dimensions, mean diameter
and volume of fluid-filled areas of the ovary. Each different
volume of cyst or follicle is color coded separately,
SonoAVC can evaluate follicular development within the
ovary [5].
Power Doppler ultrasound can provide information on
the quantity of moving blood cells per volume, which will
demonstrate the real vascularity of the ovary. Several
indices for 3D power Doppler angiography have been
proposed using the VOCAL system: MG (mean gray value), VI
[vascularization index, an estimation of vessel density,
determined by the formula: color voxels/(total voxels e
background voxels)], FI [flow index, the average intensity
of the flow, determined by the formula: weighted color
voxels/(color voxels e border voxels)], and VFI [vasculari-
zation flow index, both flow and vessel intensity, deter-
mined by the formula: weighted color voxels/(total voxels
e background voxels)] to examine and quantify the blood
flow and vascularization of the ovarian stroma [2].Recently, a new four-dimensional (4D) method for
assessment of ovarian vascularization changes during the
cardiac cycle using spatiotemporal image correlation-high
definition flow (STIC-HDF) to overcome the influence of
machine settings and attenuation is described [6]. Based on
1-cm3 spherical sampling, VI from the most vascularized
part of the ovarian stroma in 3D volumes of the 4D STIC-HDF
chain is calculated. The maximum [VI(sys)] and minimum
[VI(diast)] values are assumed to represent two different
moments of the cardiac cycle (systole and diastole),
respectively. In addition, the mean VI for all chain volumes
for one cardiac cycle is calculated. Based on these three VI
values, three new indices including volumetric systolic/
diastolic ratio (vS/D), volumetric resistance index (vRI) and
volumetric pulsatility index (vPI) are calculated. These
volumetric Doppler indices overcome the influence of angle
of insonation and vessel diameter by application of ratios
between values obtained within a cardiac cycle.Ovary
Three perpendicular planes of bilateral ovaries are rotat-
able to obtain the largest dimensions after the digital data
have been documented using 3D ultrasonography [3].
Stroma and volume determinations can be obtained more
accurately by 3D images than by conventional 2D ultraso-
nography. 3D ultrasonography not only facilitates noninva-
sive retrospective evaluation and volume calculation but
also shortens examination time without increasing patient
discomfort.
The ovarian volume, number and volume of antral
follicles, and ovarian power Doppler vascular indices can be
assessed easily by 3D transvaginal grayscale and power
Doppler ultrasound [7]. The right ovary is larger and
contains more follicles than the left one in asymptomatic
women aged 20e29 years with follicles 2e10 mm, on
menstrual cycle day 4e8, using combined oral contracep-
tives. The differences between the right and left ovary are
less obvious in women aged 30e39 years. Ovarian volume
tends to be smaller in women aged 20e29 years than in
those aged 30e39 years, but there are no clear differences.
There is no statistical significance in the size of the largest
follicle, total follicular volume and vascular indices
between the age groups. The flow intensity in ovarian
stroma decreases along with the aging process, using 3D
power Doppler ultrasound [8]. The vascular indices,
including VI, FI and VFI, all decrease significantly in the
order of premenopause, perimenopause, and then post-
menopause. However, this situation is reversed after
3 months of continuousecombined hormone replacement
therapy [9]. All 3D power Doppler indices of ovarian stromal
flow show a significant increase after treatment.
SonoAVC with 3D ultrasound examination can evaluate
the different stages of follicular development within the
ovary [5]. This 3D automated technique for the measure-
ment of antral follicle number and size is significantly
quicker than 2D ultrasound imaging [10]. However, fewer
antral follicles are found when SonoAVC software program
is used to analyze 3D ultrasound data.
The median VI, FI and VFI calculated using HDF are
significantly higher when compared with conventional
138 M.-H. Wu et al.power Doppler imaging in the endometrium of asymptom-
atic premenopausal women undergoing 3D transvaginal
sonography [11]. When assessing ovarian vascularization
with these 3D vascular indices using STIC-HDF throughout
the cardiac cycle, the mean VI during systole is significantly
higher than that during diastole, which means VI calcula-
tion is affected by the time in the cardiac cycle when the
measurement is taken [6]. However, the mean FI values
during systole and diastole remain constant in the normal
nondominant ovary. When further assessing the new volu-
metric impedance indices of ovarian vascularization, using
STIC-HDF technology is also reproducible [12].Polycystic ovarian syndrome (PCOS)
PCOS is a common cause of ovarian dysfunction and anov-
ulation in women of reproductive age. The ovaries of the
patients with PCOS are larger in size, area and volume when
compared with those of normal controls [3]. The Rotterdam
ESHRE/ASRM-sponsored PCOS 2003 consensus workshop
group define the ultrasound criteria of PCOS as the pres-
ence of at least 12 follicles in each ovary, which measure
2e9 mm in diameter, and/or increased ovarian volume
(>10 mL) [13]. In our study, the mean ovarian volume using
3D transvaginal ultrasound was 11.3  3.5 cm3 in PCOS
patients (compared with 5.5  1.4 cm3 in the control
group), which is near the value of the revised Rotterdam
consensus ultrasound diagnostic criteria for PCOS. Although
polycystic ovary ultrasound appearance is not a prerequi-
site for the diagnosis of PCOS, ovarian stromal area/total
area ratio is the most efficient diagnostic indicator for
hyperandrogenism that is significantly correlated with
androgen levels [14].
Our study further demonstrated increased VI, FI and VFI
in the ovarian stromal Doppler signals in PCOS assessed on
day 2 or day 3 of the menstrual cycle using 3D power
Doppler ultrasound [15]. This result may explain the
excessive response observed during gonadotropin adminis-
tration in women with PCOS, which leads to ovarian
hyperstimulation syndrome. Ovarian VI and VFI measured
by 3D power Doppler are significantly higher in PCOS women
in the study of Mala et al [16], which is similar to our
results. In a recent caseecontrol 4D STIC-HDF transvaginal
ultrasound study, mean VI(sys) and mean VI(diast) of
ovarian stroma were significantly higher in PCOS women
compared with controls [17]. Increased uterine artery PI
and RI and lower ovarian PI and RI measured by 2D Doppler
imaging in PCOS women are found when compared with
controls [16]. Furthermore, median vS/D, mean vRI and
median vPI of ovarian stroma are also significantly lower in
PCOS women by 4D STIC-HDF study [17]. These results
suggest lower impedance to flow in ovarian stromal vessels
in PCOS women. However, stromal volume, echogenicity
(mean gray value) and vascularity (FI) of 3D ultrasound
measurements in Chinese women with PCOS are signifi-
cantly lower than those in Caucasian women with PCOS
[18]. This supports the concept that ovarian characteristics
of PCOS by 3D ultrasound may be influenced by ethnicity or
phenotypic expression. Similarly, genetic variation may be
another cause of different PCOS expression. In our study,
there were ethnic and racial variations in the prevalence ofinsulin receptor substrate (IRS)-2 Gly1057Asp poly-
morphisms [19]. The homozygous IRS-2 Asp1057 allele was
the common genotype in IRS-2 Gly1057Asp polymorphisms
in the Taiwanese female population. The frequency of this
IRS-2 polymorphism is higher in PCOS patients when
compared with normal controls. However, there is no
difference between PCOS and normal women for this
polymorphism, and women homozygous for the Gly1057
allele is the common genotype in Greek populations [20].
Laparoscopic ovarian drilling for clomiphene-resistant
PCOS women increases ovulation rate and cumulative
pregnancy rate. It may result in a transient increase, with
a subsequent significant reduction, in ovarian volume by 3D
ultrasound evaluation after laparoscopic ovarian drilling
[21]. In young PCOS women who received laparoscopic
ovarian drilling, the parameters in intraovarian stroma
after operative treatment demonstrated significantly
decreased VI and VFI by 3D transabdominal power Doppler
ultrasound in our study [22]. Laparoscopic ovarian drilling
treatment affects ovarian stromal blood flow dynamics in
short-term follow-up that may be beneficial to endocrine
profiles and intraovarian stromal flow in PCOS patients. In
addition, there is a positive correlation between plasma
levels of anti-Mu¨llerian hormone and ovarian stromal blood
flow changes using 3D power Doppler ultrasonography in
PCOS women, including before and after laparoscopic
ovarian drilling treatment [23]. Plasma level of anti-Mu¨lle-
rian hormone is increased in PCOS women and is signifi-
cantly decreased after laparoscopic surgery, similar to the
changes in ovarian stromal blood flow Doppler indices.Ovarian endometriosis
Endometriosis is a polygenic disease with a complex,
multifactorial etiology that reduces the quality of life due
to chronic pelvic pain, dysmenorrhea, and dyspareunia
[24]. Ultrasound is an easy and noninvasive tool used in the
differential diagnosis of endometriosis, especially before
surgical intervention of ovarian endometrioma [25]. Most of
the cases with ovarian endometrioma can be found through
abdominal or transvaginal ultrasound with good accuracy.
The classical pictures of ovarian endometrioma present as
cysts with homogeneous hypoechogenic content (such as
ground glass appearance) and are often referred as choc-
olate cysts. Sometimes, it is necessary to differentiate
various benign and malignant tumors with ovarian endo-
metrioma. When an ovarian cyst contains a fluidefluid level
or fishnet appearance from ultrasound imaging, it needs to
be differentiated from the possibility of a hemorrhagic
functional cyst. When the endometriotic cyst contains
a solid appearance or internal septation, it may be due to
reactive fibrosis or retracted blood clots without vascu-
larity, by Doppler analysis. The typical vascularity pattern
of ovarian endometrioma is the pericystic flow near the
ovarian hilus. The use of color Doppler imaging does not
improve the accuracy of the diagnosis of ovarian endome-
trioma, but can reduce the likelihood of malignancy.
The sonographic tissue characterization can be assessed
with mean gray value (MGV) of the 3D volume, which
represents the mean intensity of gray-scale voxels (the
smallest unit of volume) within the ovary. When assessing
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differentiating ovarian endometriomas from other ovarian
cysts, cyst content MGV is higher in ovarian endometrioma
than in other unilocular ovarian cysts that may contribute
to the diagnosis of ovarian endometrioma [26]. In addition,
about 7% of adnexal masses cannot be classified as benign
or malignant using subjective assessment of gray-scale and
Doppler ultrasound findings [27]. 3D ultrasonography can
easily localize the distribution of vascularity via rotation of
the 3D ultrasound planes, which helps to discriminate
benign from malignant ovarian tumors [28].
The gold standard method for the diagnosis of endo-
metriosis is laparoscopy, but surgery for ovarian endome-
trioma may decrease ovarian reserve, which may impair
fertility. Laparoscopic excision of ovarian endometrioma is
still associated with a high recurrence rate, and surgical
treatment prior to in vitro fertilization (IVF) has no addi-
tional benefit over expectant management [29]. The use of
laparoscopy for women undergoing assisted reproductive
technology has recently been challenged. We use 3D power
Doppler scan to demonstrate the dynamic vascularity and
to provide a prognostic tool for IVF outcomes in patients
with endometriomas. Decreased oocyte retrieval numbers
and pregnancy rates are found in women undergoing IVF
after laparoscopic surgery for ovarian endometriomas
compared with women with tubal infertility [30]. Intra-
ovarian stromal blood flow parameters using 3D power
Doppler ultrasound demonstrate decreased VI, FI and VFI in
the endometriotic group. It may be an initial predictor of
a decreased ovarian reserve before the increase of follicle
stimulating hormone in early follicular phase. These results
may be due to a diminished ovarian reserve after conser-
vative surgery for endometrioma, which leads to ovarian
damage and decreased intraovarian vascularity. In addi-
tion, the follicular fluid leptin level is negatively correlated
with ovarian stromal FI in women with tubal infertility,
however, there is no such correlation in women with
endometrioma after surgery [30]. This decreased FI, which
may be secondary to reduced blood flow through the
ovarian stroma, leads to follicular hypoxia followed by the
secretion of several angiogenic factors, such as leptin, in
the ovarian follicles. Deficient angiogenic responses in the
ovarian cortices in women with endometrioma after surgery
may lose the negative correlation between follicular fluid
leptin and intraovarian FI. Therefore, women with minimal
and mild endometriosis may choose simultaneous laparos-
copy combined with a modified IVF (gonadotropin-releasing
hormone antagonist) protocol [31]. It will shorten the time
to pregnancy with a high cumulative pregnancy rate after
complete surgical removal of all visible endometriotic
lesions. Traditional gonadotropin-releasing hormone
agonist IVF protocol is a valid option for those with more
severe stages of endometriosis after laparoscopic treat-
ment without restored fertility.Ovulation induction and infertility
The ultrasound assessment of follicular maturity to decide
the time of human chorionic gonadotropin (hCG) injection
is important in the process of all assisted reproductive
techniques. 3D and power Doppler ultrasound examinationbefore giving hCG may help to assess more accurately
follicular diameter and volume measurement and to iden-
tify the presence of cumulus. This will evaluate the
parameters of perifollicular vascularity to ensure the
presence of a mature ovum in the follicle that may improve
pregnancy rates in intrauterine insemination cycles [32].
The follicular volume is higher in the anovulatory intra-
uterine insemination cycle [33]. Periovulatory subfollicular
VI and VFI are low in cycles that achieve pregnancy, which
means they may be used as markers of follicular quality and
pregnancy predictors [33].
In our previous studies, 3D power Doppler ultrasono-
graphic indices were used to evaluate ovarian stromal blood
flow and vascularization during gonadotropin administra-
tion in controlled ovarian hyperstimulation. The ovarian
stromal VI, FI and VFI were significantly increased in hyper-
responders [34], and decreased in women with poor
response to ovarian stimulation when compared with
women with normal response [35]. However, Jayaprakasan
et al have demonstrated that the antral follicle count is the
single best predictor of poor ovarian response [36]. Ovarian
vascularity indices measured by 3D ultrasound are not
decreased in women with poor response during IVF treat-
ment. They also show that antral follicle count is the only
significant predictor of ovarian hyperstimulation syndrome
during IVF [37]. There are no significant differences in
ovarian volume and blood flow indices including VI, FI and
VFI between women developing ovarian hyperstimulation
syndrome and normal control. These 3D studies to evaluate
IVF outcome are still controversial, therefore, further
research is warranted.
SonoAVC is a new technology that can be used in daily
practice especially for infertile women undergoing assisted
reproduction treatment. This 3D software program can
provides automated measurements of hypoechogenic areas
such as antral follicle number and size within a shorter
time. The number of antral follicles measuring 2e4 mm in
diameter is an independent, significant predictor of preg-
nancy following IVF treatment, via multiple logistic
regression analysis using SonoAVC [38]. SonoAVC can further
evaluate stimulated ovaries for timing hCG administration
based on follicular volume estimation rather than follicular
diameter. When follicle volume is automatically measured
at >0.6 mL on the day of hCG administration, it will be easy
to find mature oocytes at the time of egg retrieval [39].
However, SonoAVC does not improve the clinical outcome
of assisted reproduction treatment in the determining the
timing of final follicle maturation and egg retrieval than
those made from 2D ultrasound [40].Ovarian malignancy
It is important to be aware of the possibility of ovarian
cancer before surgical treatment for an adnexal mass.
Ultrasound examination is a useful method to diagnose
differentially the adnexal lesions from any chance of
malignancy. Two widely used ultrasound methods, namely
the risk of malignancy index and subjective assessment by
ultrasound contribute to discriminating malignant from
benign ovarian masses in preoperative assessment [41].
The risk of malignancy index combines ultrasound
140 M.-H. Wu et al.morphological score, serum cancer antigen 125 levels and
menopausal status. There are several morphological and
vascular parameters to evaluate the adnexal cysts by
transvaginal color Doppler ultrasound, to exclude the
possibility of ovarian malignancy in preoperative evalua-
tion, including the presence of vessels and its location
(central or peripheral), peak systolic velocity, RI and PI of
the lesion vascularity [42]. However, there is still an over-
lap of these parameters between benign and malignant
tumors. The best parameters to differentiate malignant
cancers from benign lesions are the lowest Doppler RI with
a cutoff value of 0.45 and central tumor vessel location.
3D ultrasound is a reproducible imaging technique to
improve diagnostic accuracy for assessing ovarian cancers.
It has both a higher sensitivity and specificity for preoper-
ative identification of suspicious adnexal mass when
compared to conventional 2D ultrasonography [43]. Using
3D power Doppler ultrasound evaluation, the mean gray
index and the FI, as well as the central localization of
vessels in the tumor, are important parameters contributing
to the differentiation between benign and malignant
ovarian masses [44]. Mean VI and VFI by 3D power Doppler
ultrasound are significantly higher in advanced-stage
cancers and metastatic ovarian tumors as compared with
early-stage ovarian cancers [45]. When using spherical
sampling with the VOCAL system for calculating 3D power
Doppler vascular indices, the median VI, FI and VFI for all
sphere volumes are significantly higher in malignant
adnexal tumors [46]. VI is significantly more specific than
are VFI and FI. However, sphere volume does not affect the
performance of 3D power Doppler sampling for predicting
malignancy in vascularized adnexal tumors.Conclusion
Although conventional 2D ultrasound already is an easy,
noninvasive and valuable diagnostic tool in the evaluation
of the ovary during clinical practice in the field of obstetrics
and gynecology, 3D ultrasound is an emerging technology
that allows physicians to comprehend and evaluate with
ease the sophisticated anatomy of the ovary observed from
any arbitrary planes. The application of 3D power Doppler
and some new software programs further the clinical role of
3D ultrasound to provide substantial assistance in pelvic
imaging. However, 3D ultrasound still needs more experi-
ence in training and operating than 2D ultrasound. Further
research should be conducted to explore more potential
uses of 3D and power Doppler ultrasonography to provide
enhanced depiction of ovarian morphology and vascularity.References
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